Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Lyra Therapeutics, Inc. (LYRA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/12/2023 |
4/A
| Palasis Maria (President & CEO) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 150,000 options
@ $2.99, valued at
$448.5k
|
|
| 07/05/2023 |
4
| TOBIN JAMES R (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $4.11, valued at
$82.2k
|
|
| 07/05/2023 |
4
| Smith W Bradford (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $4.11, valued at
$82.2k
|
|
| 07/05/2023 |
4
| Poukalov Konstantin (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $4.11, valued at
$82.2k
|
|
| 07/05/2023 |
4
| ALTMAN MICHAEL SETH (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $4.11, valued at
$82.2k
|
|
| 07/05/2023 |
4
| MERRIFIELD C ANN (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $4.11, valued at
$82.2k
|
|
| 07/05/2023 |
4
| ANDERSON EDWARD T (10% Owner) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $4.11, valued at
$82.2k
|
|
| 07/05/2023 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $4.11, valued at
$82.2k
|
|
| 02/28/2023 |
4
| Bishop John E (Chief Technology Officer) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 220,000 options
@ $2.31, valued at
$508.2k
|
|
| 02/28/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Waksal Harlan (Executive Chair) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 200,000 options
@ $2.85, valued at
$570k
|
|
| 02/02/2023 |
4
| Noyes Corinne (See Remarks) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 36,667 shares
@ $0
Granted 55,000 options
@ $2.85, valued at
$156.8k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Palasis Maria (President & CEO) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 250,000 options
@ $2.85, valued at
$712.5k
|
|
| 02/02/2023 |
4
| Nieman Richard (Chief Medical Officer) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 55,537 options
@ $2.85, valued at
$158.3k
|
|
| 07/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/21/2022 |
4
| MERRIFIELD C ANN (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 7,250 options
@ $5.09, valued at
$36.9k
|
|
| 06/21/2022 |
4
| ALTMAN MICHAEL SETH (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 7,250 options
@ $5.09, valued at
$36.9k
|
|
| 06/21/2022 |
4
| Smith W Bradford (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 7,250 options
@ $5.09, valued at
$36.9k
|
|
| 06/21/2022 |
4
| Poukalov Konstantin (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 7,250 options
@ $5.09, valued at
$36.9k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 7,250 options
@ $5.09, valued at
$36.9k
|
|
| 06/13/2022 |
4
| MERRIFIELD C ANN (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Bought 4,000 shares
@ $5.05, valued at
$20.2k
|
|
| 05/17/2022 |
4
| MERRIFIELD C ANN (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Bought 3,500 shares
@ $4.813, valued at
$16.8k
Bought 328 shares
@ $5, valued at
$1.6k
|
|
| 04/14/2022 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Bought 5,924,170 shares
@ $4.22, valued at
$25M
|
|
| 04/14/2022 |
4
| NBVM GP, LLC (10% Owner) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Bought 1,076,851 shares
@ $4.22, valued at
$4.5M
Bought 527,806 shares
@ $4.22, valued at
$2.2M
Bought 765,010 shares
@ $4.22, valued at
$3.2M
|
|
| 04/14/2022 |
4
| ANDERSON EDWARD T (10% Owner) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Bought 1,076,851 shares
@ $4.22, valued at
$4.5M
Bought 527,806 shares
@ $4.22, valued at
$2.2M
Bought 765,010 shares
@ $4.22, valued at
$3.2M
Bought 118,483 shares
@ $4.22, valued at
$500k
|
|
| 04/13/2022 |
4
| Waksal Harlan (Executive Chair) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Bought 236,966 shares
@ $4.22, valued at
$1000k
|
|
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/18/2022 |
4
| Palasis Maria (President & CEO) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 175,000 options
@ $4.21, valued at
$736.8k
|
|
|
|
|